UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
43.25
-0.70 (-1.59%)
Sep 18, 2026, 4:00 PM EDT - Market closed
UroGen Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $75 | Buy | Reiterates | $75 | +73.41% | Aug 20, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 → $60 | Buy | Reiterates | $50 → $60 | +38.73% | Aug 6, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $44 → $48 | Hold | Maintains | $44 → $48 | +10.98% | Aug 6, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $42 → $58 | Buy | Maintains | $42 → $58 | +34.10% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $50 → $60 | Buy | Reiterates | $50 → $60 | +38.73% | Aug 5, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $43 | Buy | Initiates | $43 | -0.58% | May 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 | Buy | Maintains | $40 | -7.51% | Apr 20, 2026 |
| Jefferies | Jefferies | Buy Initiates $40 | Buy | Initiates | $40 | -7.51% | Apr 9, 2026 |